Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milovan Stojanovic

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Current Vascular Pharmacology|February 1, 2023
Significance of Beta-Blocker in Patients with Hypertensive Left Ventricular Hypertrophy and Myocardial IschemiaGoran Koracevic, Slađana Mićić, Milovan Stojanovic, et al.
Current Hypertension Reviews|March 25, 2026
What is the Target Resting Heart Rate in Guidelines on Hypertension?Goran Koracevic, Milovan Stojanovic, Miloje Tomasevic, et al.
Current Vascular Pharmacology|January 24, 2025
Introducing the Concept of Hypertensive Heart Disease to Improve Hypertensive Left Ventricular HypertrophyGoran Koracevic, Milovan Stojanovic, Marija Zdravkovic, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|August 31, 2022
A Discrepancy: Calcium Channel Blockers Are Effective for the Treatment of Hypertensive Left Ventricular Hypertrophy but Not as Effective for Prevention of Heart FailureGoran Koracevic, Zoran Perisic, Maja Stanojkovic, et al.
The National Medical Journal of India|May 1, 2024
Blood pressure cut-offs to diagnose impending hypertensive emergency depend on previous hypertension-mediated organ damage and comorbid conditionsGoran Koracevic, Milovan Stojanovic, Dragan Lovic, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 9, 2020
Beta blocker rebound phenomenon is important, but we do not know its definition, incidence or optimal prevention strategiesGoran Koracevic, Sladjana Micic, Milovan Stojanovic, et al.
Current Pharmaceutical Design|May 20, 2022
Beta Blockers can Mask not only Hypoglycemia but also HypotensionGoran Koracevic, Sladjana Micic, Milovan Stojanovic, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Current Vascular Pharmacology|February 1, 2023
Significance of Beta-Blocker in Patients with Hypertensive Left Ventricular Hypertrophy and Myocardial IschemiaGoran Koracevic, Slađana Mićić, Milovan Stojanovic, et al.
Current Hypertension Reviews|March 25, 2026
What is the Target Resting Heart Rate in Guidelines on Hypertension?Goran Koracevic, Milovan Stojanovic, Miloje Tomasevic, et al.
Current Vascular Pharmacology|January 24, 2025
Introducing the Concept of Hypertensive Heart Disease to Improve Hypertensive Left Ventricular HypertrophyGoran Koracevic, Milovan Stojanovic, Marija Zdravkovic, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|August 31, 2022
A Discrepancy: Calcium Channel Blockers Are Effective for the Treatment of Hypertensive Left Ventricular Hypertrophy but Not as Effective for Prevention of Heart FailureGoran Koracevic, Zoran Perisic, Maja Stanojkovic, et al.
The National Medical Journal of India|May 1, 2024
Blood pressure cut-offs to diagnose impending hypertensive emergency depend on previous hypertension-mediated organ damage and comorbid conditionsGoran Koracevic, Milovan Stojanovic, Dragan Lovic, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 9, 2020
Beta blocker rebound phenomenon is important, but we do not know its definition, incidence or optimal prevention strategiesGoran Koracevic, Sladjana Micic, Milovan Stojanovic, et al.
Current Pharmaceutical Design|May 20, 2022
Beta Blockers can Mask not only Hypoglycemia but also HypotensionGoran Koracevic, Sladjana Micic, Milovan Stojanovic, et al.
Pageof 2